Improving the effectiveness and delivery of pre-exposure prophylaxis (PrEP) to people who inject drugs.
Level V
Where this comes from
- Record sourced from PubMed, PMID 27730702.
- Also identified by DOI 10.1111/add.13597 and PMC identifier 6659115.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Given evidence to date, pre-exposure prophylaxis (PrEP) for people who inject drugs should be implemented alongside efforts to improve access to existing evidence-based HIV prevention interventions, including antiretroviral therapy and opioid agonist treatments. The criminalization and marginalization of people who inject drugs has and will continue to limit the effectiveness of HIV prevention strategies, including PrEP.
Medical subject headings
- Pharmaceutical Preparations
- Pre-Exposure Prophylaxis